CGT Basically I have no faith in management. As Muzarati commented "Current BTA mgmt haven't finished and completed any projects to the revenue stage. It's been a long time between drinks." I dont give them great credit for getting BARDA funding (although at least they didn't stuff it up). I think BARDA funding was pretty much a cetainty. In my view BTA have one great asset. As I said everything else in the pipeline is high risk and a drain on finances with very little clarity about potentail reward given the long period before they will (if successful) generate any revenue. I also think because of the period until phase 3 trials are completed (if they get to that stage) there is additional high risk that other alternatives will be developed and therefore its difficult to even predict what the possible rewards will be.
BTA Price at posting:
$1.09 Sentiment: Hold Disclosure: Held
